Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions
- PMID: 272083
- DOI: 10.1007/BF01556181
Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions
Similar articles
-
BCG and cancer.N Engl J Med. 1974 Jun 27;290(26):1458-69. doi: 10.1056/NEJM197406272902605. N Engl J Med. 1974. PMID: 4598691 Review. No abstract available.
-
Immunotherapy for malignant disease.Med Lett Drugs Ther. 1976 Sep 24;18(20):83-4. Med Lett Drugs Ther. 1976. PMID: 1066519 No abstract available.
-
Immunotherapy from malignant disease.Annu Rev Med. 1978;29:231-83. doi: 10.1146/annurev.me.29.020178.001311. Annu Rev Med. 1978. PMID: 348035 Review. No abstract available.
-
Use of BCG in the treatment of human neoplasms: a review.Semin Oncol. 1974 Dec;1(4):337-50. Semin Oncol. 1974. PMID: 4620439 Review. No abstract available.
-
BCG as adjuvant immunotherapy for neoplasia.Annu Rev Med. 1977;28:489-515. doi: 10.1146/annurev.me.28.020177.002421. Annu Rev Med. 1977. PMID: 324372 Review. No abstract available.